The U.S. Defense Health Agency awarded a $240,000 Project Grant to The Cleveland Clinic Foundation under the Military Medical Research and Development program (CFDA 12.420) on March 15, 2025. This grant supports the research project "EXPLORING CAUSALITY AND MECHANISM OF AR ECDNA IN MALIGNANT PROSTATE CANCER PROGRESSION" over a 2-year period until March 14, 2027. As a leading non-profit academic medical center, The Cleveland Clinic Foundation will leverage its expertise in oncology, genetics, and biomedical research to conduct innovative studies on prostate cancer progression. This award contributes to the program's objective of advancing medical solutions for military personnel and the broader public through impactful biomedical research across diverse disciplines.
Generated 3/18/25, 2:05 AM